Form 4: Becton Dickinson Executive Christopher DelOrefice Reports Stock Transactions

Executive Vice President and Chief Financial Officer of Becton Dickinson, Christopher DelOrefice, reports acquisition and disposal of company stock and stock appreciation rights.

Summary

• Christopher DelOrefice, EVP & Chief Financial Officer of Becton Dickinson, reported several transactions involving company stock on November 26, 2024.
• These transactions include the acquisition of 4,884 restricted stock units and 9,015 shares from vesting performance-based equity awards.
• Additionally, 5,192 shares were disposed of to cover withholding taxes related to the vesting of performance units and restricted stock units.
• DelOrefice also acquired 19,138 stock appreciation rights with an exercise price of $224.25, vesting in four annual installments starting November 26, 2025.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of insider transactions, which is neither positive nor negative in itself. The acquisition of stock and stock appreciation rights is a positive sign of alignment with company performance, but the disposal of shares for tax purposes is neutral.

Positives

• The acquisition of restricted stock units and performance-based equity awards indicates continued alignment of executive interests with company performance.
• The acquisition of stock appreciation rights provides a potential future benefit to the executive based on the company's stock performance.

Negatives

• The disposal of 5,192 shares to cover withholding taxes reduces the executive's direct shareholding.

Risks

• The value of the stock appreciation rights is dependent on the future performance of the company's stock price.
• Changes in tax laws could impact the value of the stock transactions.

Future Outlook

The stock appreciation rights vest in four annual installments beginning November 26, 2025, indicating a long-term incentive for the executive.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into executive compensation and ownership.

Comparison to Industry Standards

• Stock-based compensation, including restricted stock units and stock appreciation rights, is a common practice among large publicly traded companies like Becton Dickinson.
• Companies such as Medtronic (MDT) and Abbott Laboratories (ABT) also use similar equity-based compensation plans for their executives.
• The vesting schedules and terms of these awards are generally aligned with industry standards for executive compensation.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation practices.
• The vesting of stock appreciation rights aligns executive interests with long-term shareholder value.

Key Dates

Keywords

Becton Dickinson, BDX, Christopher DelOrefice, stock transactions, restricted stock units, performance-based equity, stock appreciation rights, executive compensation, insider trading